Literature DB >> 24845497

Novel inhibitor of DNA ligase IV with a promising cancer therapeutic potential.

Ashwin Kotnis1, Rita Mulherkar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24845497     DOI： 10.1007/s12038-014-9433-0

Source DB:  PubMed          Journal:  J Biosci        ISSN： 0250-5991            Impact factor:   1.826


× No keyword cloud information.
  3 in total

Review 1.  The concept of synthetic lethality in the context of anticancer therapy.

Authors:  William G Kaelin
Journal:  Nat Rev Cancer       Date:  2005-09       Impact factor: 60.716

2.  Rational design of human DNA ligase inhibitors that target cellular DNA replication and repair.

Authors:  Xi Chen; Shijun Zhong; Xiao Zhu; Barbara Dziegielewska; Tom Ellenberger; Gerald M Wilson; Alexander D MacKerell; Alan E Tomkinson
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

3.  An inhibitor of nonhomologous end-joining abrogates double-strand break repair and impedes cancer progression.

Authors:  Mrinal Srivastava; Mridula Nambiar; Sheetal Sharma; Subhas S Karki; G Goldsmith; Mahesh Hegde; Sujeet Kumar; Monica Pandey; Ram K Singh; Pritha Ray; Renuka Natarajan; Madhura Kelkar; Abhijit De; Bibha Choudhary; Sathees C Raghavan
Journal:  Cell       Date:  2012-12-21       Impact factor: 41.582
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.